Precision BioSciences Cash from Financing (Quarterly) Insights

Precision BioSciences Inc (DTIL)

7.70 -0.38 (-4.70%) USD | NASDAQ | Nov 14, 16:00

7.70 0.00 (0.00%) After-Hours: 20:00

Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2018. Upgrade now.

Date	Value
September 30, 2024	3.733M
June 30, 2024	0.702M
March 31, 2024	40.10M
December 31, 2023	2.828M
September 30, 2023	-0.034M
June 30, 2023	1.852M
March 31, 2023	0.741M
December 31, 2022	0.00
September 30, 2022	-0.18M
June 30, 2022	92.92M
March 31, 2022	2.249M
December 31, 2021	8.378M
September 30, 2021	11.92M
June 30, 2021	13.51M

Date	Value
March 31, 2021	36.72M
December 31, 2020	0.198M
September 30, 2020	0.532M
June 30, 2020	0.285M
March 31, 2020	0.314M
December 31, 2019	0.706M
September 30, 2019	0.061M
June 30, 2019	134.31M
March 31, 2019	38.30M
December 31, 2018	-1.592M
September 30, 2018	21.32M
June 30, 2018	88.03M
March 31, 2018	0.02M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

-0.18M

Minimum

Sep 2022

92.92M

Maximum

Jun 2022

10.87M

Average

1.296M

Median

Cash from Financing (Quarterly) Benchmarks

Assembly Biosciences Inc	12.45M
TG Therapeutics Inc	134.45M
Protagonist Therapeutics Inc	12.05M
Alector Inc	0.00
Entrada Therapeutics Inc	-0.011M

Cash from Financing (Quarterly) Related Metrics

Cash from Operations (Quarterly)	-5.912M
Cash from Investing (Quarterly)	-0.064M
Free Cash Flow	-48.36M
Free Cash Flow Per Share (Quarterly)	-0.8201
Free Cash Flow to Equity (Quarterly)	-5.76M
Free Cash Flow Yield	-107.5%